ArticleNature communications2026

Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.

Jana Samarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.